Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. Avidity Biosciences
RNA

Buy Avidity Biosciences (RNA) Stock

RNA
See RNA stock price and Buy/Sell Avidity Biosciences with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
RNA

Avidity Biosciences (RNA)

About Avidity Biosciences (RNA)

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell ...Read more
Market Cap
$839.77M
1 Year High
$29.25
Volume
269.72k
1 Year Low
$10.89
Price to Earnings Ratio
Open
$15.86
Dividend Rate
High
$16.94
Dividend Yield
Low
$15.56

Community

People who own or watch RNA stock

Avidity Biosciences Price Targets

What analysts think RNA stock price will be.
$16.50
$40.71
146.7% Upside
$10$43

Avidity Biosciences Stock Rating

What analysts recommend for RNA stock, on a scale from 1(buy) to 5(sell).
Strong Buy1 / 5
BuyHoldSell

Avidity Biosciences Stock Earnings

The value each RNA share was expected to gain vs. the value that each RNA share actually gained.
Expected
Actual

Avidity Biosciences Stock News

Frequently Asked Questions (FAQ)

As of Sep 28, 2022, the market cap for RNA stock is $839.77M

The 52-week high for RNA stock is $29.25. The current RNA stock price $16.5 is 43.59% below its 52-week high

The 52-week low for RNA stock is $10.89. The current RNA stock price $16.5 has increased 34.00% from its 52-week low

No, the RNA stock does not pay dividends to its shareholders

The target price for RNA stock is $40.71 based on the average of what a group of analyst think RNA stock could be worth at a future date. This is not a prediction by Public.com

Buy Avidity Biosciences (RNA) Stock

RNA
See RNA stock price and Buy/Sell Avidity Biosciences with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch RNA stock
  • poundcakedz2021 avatar
  • outac0ntrol avatar
  • JoyfulSpectre avatar
  • mommamiller3 avatar
  • MrRaider avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.